gabapentin

Generic: gabapentin

Labeler: atlantic biologicals corp.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler atlantic biologicals corp.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

gabapentin 250 mg/5mL

Manufacturer
ATLANTIC BIOLOGICALS CORP.

Identifiers & Regulatory

Product NDC 17856-0600
Product ID 17856-0600_361f9f34-f186-da49-e063-6394a90a3d51
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076403
Listing Expiration 2026-12-31
Marketing Start 2018-06-29

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 178560600
Hyphenated Format 17856-0600

Supplemental Identifiers

RxCUI
283523
UNII
6CW7F3G59X
NUI
N0000008486

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA076403 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/5mL
source: ndc
Packaging
  • 72 CUP, UNIT-DOSE in 1 BOX (17856-0600-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0600-4)
  • 72 CUP, UNIT-DOSE in 1 BOX (17856-0600-2) / 6 mL in 1 CUP, UNIT-DOSE (17856-0600-5)
  • 5 BOX, UNIT-DOSE in 1 SYRINGE (17856-0600-7) / 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0600-3) / 2 mL in 1 SYRINGE (17856-0600-6)
  • 60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0600-8) / 2 mL in 1 SYRINGE (17856-0600-9)
source: ndc

Packages (4)

Ingredients (1)

gabapentin (250 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "361f9f34-f186-da49-e063-6394a90a3d51", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["283523"], "spl_set_id": ["5969f1a8-d6d5-4967-add5-4e2492354d7b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["ATLANTIC BIOLOGICALS CORP."]}, "finished": true, "packaging": [{"sample": false, "description": "72 CUP, UNIT-DOSE in 1 BOX (17856-0600-1)  / 5 mL in 1 CUP, UNIT-DOSE (17856-0600-4)", "package_ndc": "17856-0600-1", "marketing_start_date": "20240507"}, {"sample": false, "description": "72 CUP, UNIT-DOSE in 1 BOX (17856-0600-2)  / 6 mL in 1 CUP, UNIT-DOSE (17856-0600-5)", "package_ndc": "17856-0600-2", "marketing_start_date": "20240507"}, {"sample": false, "description": "5 BOX, UNIT-DOSE in 1 SYRINGE (17856-0600-7)  / 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0600-3)  / 2 mL in 1 SYRINGE (17856-0600-6)", "package_ndc": "17856-0600-7", "marketing_start_date": "20240507"}, {"sample": false, "description": "60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0600-8)  / 2 mL in 1 SYRINGE (17856-0600-9)", "package_ndc": "17856-0600-8", "marketing_start_date": "20250205"}], "brand_name": "Gabapentin", "product_id": "17856-0600_361f9f34-f186-da49-e063-6394a90a3d51", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "17856-0600", "generic_name": "gabapentin", "labeler_name": "ATLANTIC BIOLOGICALS CORP.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "250 mg/5mL"}], "application_number": "ANDA076403", "marketing_category": "ANDA", "marketing_start_date": "20180629", "listing_expiration_date": "20261231"}